CollPlant has announced that Dr. Nadav Orr has been appointed as Vice President of Research & Development, effective September 7, 2014. Dr. Nadav Orr brings over 15 years of experience in research and development, including 9 years in the development of Biosurgery products. Before joining the company, Nadav served as an Associate Director, Research and Development at Omrix Biopharmaceuticals Ltd. As part of his role at Omrix, Nadav led an international team in the development of hemostatic combination products and provided business support for production processes and products.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.224 USD | +4.10% | -2.75% | -2.60% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.60% | 71.28M | |
-10.55% | 1.15B | |
-22.77% | 125M | |
+1.63% | 58.22M | |
-1.80% | 52.14M |
- Stock Market
- Equities
- CLGN Stock
- News CollPlant Biotechnologies Ltd.
- CollPlant Appoints Dr. Nadav Orr as Vice President of Research and Development